Response to Stern
- PMID: 38156990
- DOI: 10.1016/j.gim.2023.101030
Response to Stern
Conflict of interest statement
Conflict of Interest Funding and support listed here did not support development of this document unless included in the acknowledgements section. H.H. is supported by the Cancer Research CRUK Catalyst Award, CanGene-CanVar the National Institute for Health and Care Research (NIHR) Exeter Biomedical Research Centre (BRC). The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care. H.H. has served on advisory boards for AstraZeneca. L.M.A. is an employee and shareholder of Illumina, Inc. W.D.F. is supported by the Canadian Institutes of Health Research. R.S. is supported by the German Cancer Aid and the Federal Ministry of Education and Research (BMBF), Germany. D.R.S. is supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute (NCI), Rockville, Maryland, and also performs contract clinical telehealth services for Genome Medical, Inc. in accordance with relevant NCI ethics policies. The other authors declare no competing interests. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.
Publication types
LinkOut - more resources
Full Text Sources
